Integration of class I HDAC inhibitors into current treatments for prostate cancer.

Judith Manley, Pamela Maxwell, Melissa LaBonte Wilson*

*Corresponding author for this work

Research output: Contribution to conferenceAbstractpeer-review

Original languageEnglish
Publication statusPublished - 25 Aug 2019
EventFEBS Advanced Lecture Course: Epigenetic, nuclear receptors and disease. - Island of Spetses, Greece
Duration: 25 Aug 201930 Aug 2019

Workshop

WorkshopFEBS Advanced Lecture Course: Epigenetic, nuclear receptors and disease.
Country/TerritoryGreece
Period25/08/201930/08/2019

Cite this